Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Impact of a treatment with angiotensin receptor blocker on outcome after acute kidney injury in patients discharged from the ICU “START-or-N… Ended

2024-515845-40-00 Acute kidney injury 5 2022-11-22
A Phase II, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Canakinumab for the Treatment of Anemia in Patients with IPSS-… Ended

2024-515886-33-00 Lower-risk MDS or MDS/MPN 4 2022-03-23
Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children with Neurofibro… Ended

2024-517216-29-00 Neurofibromatosis Type 1 (NF1) Related Plexiform Neurof 3 2021-08-06
TALAMESO : A Three-Cohort Phase II trial to Assess the Efficacy of a Maintenance Treatment with TALAzoparib following First Line Platinum-ba… Ended

2024-514104-14-00 Adults subjects with advanced malignant pleural (cohort 4 2020-11-04
Avelumab Program Rollover Study Ended

2024-514274-46-00 Solid Tumors 5 2019-06-21
An open-label, multi-center rollover protocol for patients who have participated in a Novartis-sponsored ribociclib (LEE011) study and are c… Ended

2024-511125-61-00 Different types of advanced cancer 9 2017-03-08
A Phase 1, Double-blind, Randomized, Three-arm, Parallel Group Study to Compare the Pharmacokinetics and Safety of a Single Subcutaneous Dos… Halted

2024-519145-30-00 Healthy volunteers 3 2022-03-31
Safety and tolerability of medicated chewing gum with sodium alginate, calcium carbonate and sodium bicarbonate. Ended

2025-524102-15-00 No medical condition. 3 2026-04-29
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-521732-11-00 No medical condition 2 2026-03-09
Study to compare drug availability in the bloodstream of two oral formulations of dexketoprofen in healthy volunteers under fasting conditio… Ended

2025-524061-24-01 Bioequivalence clinical trial in healthy volunteers und 2 2026-02-13
A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood Ended

2025-523135-19-00 Healthy volunteer trial 3 2026-02-06
A study in healthy people to test whether BI 764198 influences the amount of metformin in the body Ended

2025-522432-14-00 Healthy volunteer trial 3 2026-02-03
OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJ… Ended

2025-524274-41-00 Healthy volunteers 3 2026-01-26
Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants. Ended

2025-523300-77-00 No medical conditions. 2 2026-01-26
A study in healthy men to test how BI 1584862 is processed in the body Ended

2025-522311-41-00 Healthy volunteer trial 3 2026-01-22
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-524035-39-00 Bioavailability study in healthy volunteers under fasti 2 2026-01-14
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended

2025-522626-12-00 No medical condition. 2 2025-12-18
Phase 1 study to investigate the pharmacokinetic profile and safety of 3 testosterone gel formulations in postmenopausal female participants… Ended

2025-522726-12-00 No medical conditions. 3 2025-12-16
A study in healthy men and women to test how BI 3000202 is taken up and processed by the body Ended

2023-510345-21-00 Healthy volunteer trial 3 2025-12-16
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin. Ended

2024-519851-27-00 No medical condition. 2 2025-12-09
Bioequivalence of Cinnarizine/Dimenhydrinate 20 mg/40 mg Tablets in Healthy Participants Under Fed Conditions. Ended

2025-523948-12-00 No medical condition. 2 2025-11-27
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3… Ended

2025-521095-66-00 Healthy volunteer trial 1 2025-11-19
A trial to evaluate the absolute bioavailability of cenerimod in healthy male participants Ended

2025-522320-27-00 Not applicable - healthy volunteer trial 3 2025-11-17
A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body Ended

2025-520656-29-00 Healthy volunteer trial 3 2025-11-03